CoChat
Sign Up
Cited by 328

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

SOX2 in development and cancer biology

Novak, Daniel, Hüser, Laura, Elton, Jonathan J., Umansky, Viktor, Altevogt, Peter, Utikal, Jochen·2020·Seminars in Cancer Biology
DOI 10.1016/j.semcancer.2019.08.007
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.semcancer.2019.08.007

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 151

  1. Gubbay, 1990, A gene mapping to the sex-determining region of the mouse Y chromosome is a member of a novel family of embryonically expressed genes, Nature, 346, 245, 10.1038/346245a0 · DOI
  2. Sinclair, 1990, A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif, Nature, 346(6281):240-4, 240, 10.1038/346240a0 · DOI
  3. Wegner, 2010, All purpose Sox: the many roles of Sox proteins in gene expression, Int. J. Biochem. Cell Biol., 42, 381, 10.1016/j.biocel.2009.07.006 · DOI
  4. Weina, 2014, SOX2 and cancer: current research and its implications in the clinic, Clin. Transl. Med., 3
  5. Stevanovic, 1994, The cDNA sequence and chromosomal location of the human SOX2 gene, Mamm. Genome, 5, 640, 10.1007/BF00411460 · DOI
  6. Castillo, 2012, The SOX family of genes in cancer development: biological relevance and opportunities for therapy, Expert Opin. Ther. Targets, 16, 903, 10.1517/14728222.2012.709239 · DOI
  7. Pan, 2011, SOX2 modulates reprogramming of gene expression in two-cell mouse Embryos, Biol. Reprod., 85, 409, 10.1095/biolreprod.111.090886 · DOI
  8. Avilion, 2003, Multipotent cell lineages in early mouse development depend on SOX2 function, Genes Dev., 17, 126, 10.1101/gad.224503 · DOI
  9. Yabuta, 2006, Gene expression dynamics during germline specification in mice identified by quantitative single-cell gene expression profiling, Biol. Reprod., 75, 705, 10.1095/biolreprod.106.053686 · DOI
  10. Wang, 2012, Cell stem cell distinct lineage specification roles for NANOG, OCT4, and SOX2 in human embryonic stem cells, Stem Cell, 10, 440
  11. Thomson, 2011, Pluripotency factors in embryonic stem cells regulate differentiation into germ layers, Cell, 145, 875, 10.1016/j.cell.2011.05.017 · DOI
  12. Takemoto, 2011, Tbx6-dependent Sox2 regulation determines neural or mesodermal fate in axial stem cells, Nature, 470, 394, 10.1038/nature09729 · DOI
  13. Pevny, 2010, Sox2 roles in neural stem cells, Int. J. Biochem. Cell Biol., 42, 421, 10.1016/j.biocel.2009.08.018 · DOI
  14. Wegner, 2005, From stem cells to neurons and glia: a Soxist’s view of neural development, Trends Neurosci., 28, 583, 10.1016/j.tins.2005.08.008 · DOI
  15. Taranova, 2006, SOX2 is a dose-dependent regulator of retinal neural progenitor competence, Genes Dev., 20, 1187, 10.1101/gad.1407906 · DOI
  16. Adameyko, 2012, Sox2 and Mitf cross-regulatory interactions consolidate progenitor and melanocyte lineages in the cranial neural crest, Development, 139, 397, 10.1242/dev.065581 · DOI
  17. Le, 2005, Analysis of congenital hypomyelinating Egr2Lo/Lo nerves identifies Sox2 as an inhibitor of Schwann cell differentiation and myelination, Proc. Natl. Acad. Sci., 102, 2596, 10.1073/pnas.0407836102 · DOI
  18. Ferri, 2004, Sox2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain, Development, 131, 3805, 10.1242/dev.01204 · DOI
  19. Cavallaro, 2008, Impaired generation of mature neurons by neural stem cells from hypomorphic Sox2 mutants, Development, 135, 541, 10.1242/dev.010801 · DOI
  20. Dabdoub, 2008, Sox2 signaling in prosensory domain specification and subsequent hair cell differentiation in the developing cochlea, Proc. Natl. Acad. Sci., 105, 18396, 10.1073/pnas.0808175105 · DOI
  21. Juuri, 2012, Sox2+ stem cells contribute to all epithelial lineages of the tooth via Sfrp5+ progenitors, Dev. Cell, 23, 317, 10.1016/j.devcel.2012.05.012 · DOI
  22. Kiernan, 2005, Sox2 is required for sensory organ development in the mammalian inner ear, Nature, 434, 1031, 10.1038/nature03487 · DOI
  23. Okubo, 2006, Sox2 is required for development of taste bud sensory cells, Genes Dev., 20, 2654, 10.1101/gad.1457106 · DOI
  24. Gontan, 2008, Sox2 is important for two crucial processes in lung development: branching morphogenesis and epithelial cell differentiation, Dev. Biol., 317, 296, 10.1016/j.ydbio.2008.02.035 · DOI
  25. Ishii, 1998, Region-specific expression of chicken Sox2 in the developing gut and lung epithelium: regulation by epithelial-mesenchymal interactions, Dev. Dyn., 213, 464, 10.1002/(SICI)1097-0177(199812)213:4<464::AID-AJA11>3.0.CO;2-Z · DOI
  26. Que, 2009, Multiple roles for Sox2 in the developing and adult mouse trachea, Development, 136, 1899, 10.1242/dev.034629 · DOI
  27. Que, 2007, Multiple dose-dependent roles for Sox2 in the patterning and differentiation of anterior foregut endoderm, Development, 134, 2521, 10.1242/dev.003855 · DOI
  28. Rendl, 2005, Molecular dissection of mesenchymal-epithelial interactions in the hair follicle, PLoS Biol., 3, e331, 10.1371/journal.pbio.0030331 · DOI
  29. Jinno, 2010, Convergent genesis of an adult neural crest-like dermal stem cell from distinct developmental origins, Stem Cells, 28, 2027, 10.1002/stem.525 · DOI
  30. Masui, 2007, Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells, Nat. Cell Biol., 9, 625, 10.1038/ncb1589 · DOI
  31. Boyer, 2005, Core transcriptional regulatory circuitry in human embryonic stem cells, Cell, 122, 947, 10.1016/j.cell.2005.08.020 · DOI · Paper page
  32. Chan, 2011, Transcriptional regulatory networks in embryonic stem cells, Prog. Drug Res., 67, 239
  33. Maherali, 2007, Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution, Cell Stem Cell, 1, 55, 10.1016/j.stem.2007.05.014 · DOI · Paper page
  34. Eminli, 2008, Reprogramming of Neural Progenitor Cells into Induced Pluripotent Stem Cells in the Absence of Exogenous Sox2 Expression, Stem Cells, 26, 2467, 10.1634/stemcells.2008-0317 · DOI
  35. Utikal, 2009, Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells, J. Cell. Sci., 122, 3502, 10.1242/jcs.054783 · DOI
  36. Bernhardt, 2012, Mediators of induced pluripotency and their role in cancer cells - current scientific knowledge and future perspectives, Biotechnol. J., 7, 810, 10.1002/biot.201100347 · DOI
  37. Ellis, 2004, SOX2, a persistent marker for multipotential neural stem cells derived from embryonic stem cells, the embryo or the adult, Dev. Neurosci., 26, 148, 10.1159/000082134 · DOI
  38. Suh, 2007, In vivo fate analysis reveals the multipotent and self-renewal capacities of Sox2+ neural stem cells in the adult Hippocampus, Cell Stem Cell, 1, 515, 10.1016/j.stem.2007.09.002 · DOI
  39. Favaro, 2009, Hippocampal development and neural stem cell maintenance require Sox2-dependent regulation of Shh, Nat. Neurosci., 12, 1248, 10.1038/nn.2397 · DOI
  40. Fauquier, 2008, SOX2-expressing progenitor cells generate all of the major cell types in the adult mouse pituitary gland, Proc. Natl. Acad. Sci., 105, 2907, 10.1073/pnas.0707886105 · DOI
  41. Biernaskie, 2009, SKPs derive from hair follicle precursors and exhibit properties of adult dermal stem cells, Cell Stem Cell, 5, 610, 10.1016/j.stem.2009.10.019 · DOI
  42. Okubo, 2009, Cell Lineage Mapping of Taste Bud Cells and Keratinocytes in the Mouse Tongue and Soft Palate, Stem Cells, 27, 442, 10.1634/stemcells.2008-0611 · DOI
  43. Arnold, 2011, Sox2+adult stem and progenitor cells are important for tissue regeneration and survival of mice, Cell Stem Cell, 9, 317, 10.1016/j.stem.2011.09.001 · DOI
  44. Han, 2014, Enhanced proliferation and differentiation of Oct4- and Sox2-overexpressing human adipose tissue mesenchymal stem cells, Exp. Mol. Med., 46
  45. Trohatou, 2014, Sox2 suppression by miR-21 governs human mesenchymal stem cell properties, Stem Cells Transl. Med., 3, 54, 10.5966/sctm.2013-0081 · DOI
  46. Yoon, 2014, SIRT1 directly regulates SOX2 to maintain self-renewal and multipotency in bone marrow-derived mesenchymal stem cells, Stem Cells, 32, 3219, 10.1002/stem.1811 · DOI
  47. Vilas, 2018, Adult Sox2+ stem cell exhaustion in mice results in cellular senescence and premature aging, Aging Cell, 17, e12834, 10.1111/acel.12834 · DOI
  48. Fantes, 2003, Mutations in SOX2 cause anophthalmia, Nat. Genet., 33, 461, 10.1038/ng1120 · DOI
  49. Kelberman, 2006, Mutations within Sox2/SOX2 are associated with abnormalities in the hypothalamo-pituitary-gonadal axis in mice and humans, J. Clin. Invest., 116, 2442
  50. Williamson, 2006, Mutations in SOX2 cause anophthalmia-esophageal-genital (AEG) syndrome, Hum. Mol. Genet., 15, 1413, 10.1093/hmg/ddl064 · DOI
  51. Hüser, 2018, Targeting SOX2 in anticancer therapy, Expert Opin. Ther. Targets, 22, 983, 10.1080/14728222.2018.1538359 · DOI
  52. Bass, 2009, SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas, Nat. Genet., 41, 1238, 10.1038/ng.465 · DOI
  53. Watanabe, 2014, SOX2 and p63 colocalize at genetic loci in squamous cell carcinomas, J. Clin. Invest., 124, 1636, 10.1172/JCI71545 · DOI
  54. Chew, 2005, Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cells, Society, 25, 6031
  55. Justilien, 2014, The PRKCI and SOX2 Oncogenes Are Coamplified and Cooperate to Activate Hedgehog Signaling in Lung Squamous Cell Carcinoma, Cancer Cell, 25, 139, 10.1016/j.ccr.2014.01.008 · DOI
  56. Schröck, 2013, Sex Determining Region Y-Box 2 (SOX2) Amplification Is an Independent Indicator of Disease Recurrence in Sinonasal Cancer, PLoS One, 8, e59201, 10.1371/journal.pone.0059201 · DOI
  57. Annovazzi, 2011, SOX2 expression and amplification in gliomas and glioma cell lines, Cancer Genomics Proteomics, 8, 139
  58. Alonso, 2011, Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas, PLoS One, 6, e26740, 10.1371/journal.pone.0026740 · DOI
  59. Vasquez, 2017, SOX2 immunity and tissue resident memory in children and young adults with glioma, J. Neurooncol., 134, 41, 10.1007/s11060-017-2515-8 · DOI
  60. Toschi, 2014, Increased SOX2 gene copy number is associated with FGFR1 and PIK3CA gene gain in non-small cell lung cancer and predicts improved survival in early stage disease, PLoS One, 9, e95303, 10.1371/journal.pone.0095303 · DOI
  61. Ying, 2016, Expression and significance of SOX2 in non-small cell lung carcinoma, Oncol. Lett., 12, 3195, 10.3892/ol.2016.5065 · DOI
  62. Chou, 2013, The emerging role of SOX2 in cell proliferation and survival and its crosstalk with oncogenic signaling in lung cancer, Stem Cells, 31, 2607, 10.1002/stem.1518 · DOI
  63. Weina, 2016, TGF- β induces SOX2 expression in a time-dependent manner in human melanoma cells, Pigment Cell Melanoma Res., 29, 453, 10.1111/pcmr.12483 · DOI
  64. Schaefer, 2017, Sox2 is dispensable for primary melanoma and metastasis formation, Oncogene, 36, 4516, 10.1038/onc.2017.55 · DOI
  65. Zhang, 2012, Sex-determining region Y-box 2 expression predicts poor prognosis in human ovarian carcinoma, Hum. Pathol., 43, 1405, 10.1016/j.humpath.2011.10.016 · DOI
  66. Ye, 2011, Expression of Sox2 in human ovarian epithelial carcinoma, J. Cancer Res. Clin. Oncol., 137, 131, 10.1007/s00432-010-0867-y · DOI
  67. Belotte, 2015, Sox2 gene amplification significantly impacts overall survival in serous epithelial ovarian cancer, Reprod. Sci., 22, 38, 10.1177/1933719114542021 · DOI
  68. Otsubo, 2008, SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis, Br. J. Cancer, 98, 824, 10.1038/sj.bjc.6604193 · DOI
  69. Wang, 2015, SOX2, a predictor of survival in gastric cancer, inhibits cell proliferation and metastasis by regulating PTEN, Cancer Lett., 358, 210, 10.1016/j.canlet.2014.12.045 · DOI
  70. Chen, 2016, SOX2 inhibits metastasis in gastric cancer, J. Cancer Res. Clin. Oncol., 142, 1221, 10.1007/s00432-016-2125-4 · DOI
  71. Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 · DOI · Paper page
  72. Kreso, 2014, Evolution of the cancer stem cell model, Cell Stem Cell, 14, 275, 10.1016/j.stem.2014.02.006 · DOI
  73. Gangemi, 2009, SOX2 Silencing in Glioblastoma Tumor-Initiating Cells Causes Stop of Proliferation and Loss of Tumorigenicity, Stem Cells, 27, 40, 10.1634/stemcells.2008-0493 · DOI
  74. Garros-Regulez, 2016, mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance, Expert Opin. Ther. Targets, 20, 393, 10.1517/14728222.2016.1151002 · DOI
  75. Ikushima, 2009, Autocrine TGF-β Signaling Maintains Tumorigenicity of Glioma-Initiating Cells through Sry-Related HMG-Box Factors, Cell Stem Cell, 5, 504, 10.1016/j.stem.2009.08.018 · DOI
  76. Hägerstrand, 2011, Identification of a SOX2-dependent subset of tumor- and sphere-forming glioblastoma cells with a distinct tyrosine kinase inhibitor sensitivity profile, Neuro Oncol., 13, 1178, 10.1093/neuonc/nor113 · DOI
  77. Velpula, 2012, A Cord blood stem cells revert glioma stem cell EMT by down regulating transcriptional activation of Sox2 and Twist1, Oncotarget., 2, 1028, 10.18632/oncotarget.367 · DOI
  78. Oppel, 2011, SOX2-RNAi attenuates S-phase entry and induces RhoA-dependent switch to protease-independent amoeboid migration in human glioma cells, Mol. Cancer, 10
  79. Vanner, 2014, Quiescent Sox2+Cells Drive Hierarchical Growth and Relapse in Sonic Hedgehog Subgroup Medulloblastoma, Cancer Cell, 26, 33, 10.1016/j.ccr.2014.05.005 · DOI
  80. Piva, 2014, Sox2 promotes tamoxifen resistance in breast cancer cells, EMBO Mol. Med., 6, 66, 10.1002/emmm.201303411 · DOI
  81. Das, 2017, Actinomycin D Down-regulates SOX2 Expression and Induces Death in Breast Cancer Stem Cells, Anticancer Res., 37, 1655, 10.21873/anticanres.11496 · DOI
  82. Gong, 2018, Transcriptional repressor GATA binding 1-mediated repression of SRY-box 2 expression suppresses cancer stem cell functions and tumor initiation, J. Biol. Chem., 293, 18646, 10.1074/jbc.RA118.003983 · DOI
  83. Lundberg, 2016, SOX2 expression is associated with a cancer stem cell state and down-regulation of CDX2 in colorectal cancer, BMC Cancer, 16
  84. Liu, 2014, Cervical cancer cells with positive Sox2 expression exhibit the properties of cancer stem cells, PLoS One, 9, e87092, 10.1371/journal.pone.0087092 · DOI
  85. Herreros-Villanueva, 2013, SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells, Oncogenesis, 2
  86. Hepburn, 2012, Side Population in Human Non-Muscle Invasive Bladder Cancer Enriches for Cancer Stem Cells That Are Maintained by MAPK Signalling, PLoS One, 7, e50690, 10.1371/journal.pone.0050690 · DOI
  87. Nakatsugawa, 2011, SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity, Lab. Investig., 91, 1796, 10.1038/labinvest.2011.140 · DOI
  88. Rybak, 2013, SOX2 plays a critical role in EGFR-mediated self-renewal of human prostate cancer stem-like cells, Cell. Signal., 25, 2734, 10.1016/j.cellsig.2013.08.041 · DOI
  89. Lee, 2014, SOX2 regulates self-renewal and tumorigenicity of stem-like cells of head and neck squamous cell carcinoma, Br. J. Cancer, 111, 2122, 10.1038/bjc.2014.528 · DOI
  90. Bourguignon, 2012, Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma, J. Biol. Chem., 287, 32800, 10.1074/jbc.M111.308528 · DOI
  91. Boumahdi, 2014, SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma, Nature, 511, 246, 10.1038/nature13305 · DOI
  92. Coppola, 2012, EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer, Mol. Cancer, 11
  93. Xiang, 2011, Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer, Br. J. Cancer, 104, 1410, 10.1038/bjc.2011.94 · DOI
  94. Hussenet, 2010, SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas, PLoS One, 5, e8960, 10.1371/journal.pone.0008960 · DOI
  95. Santini, 2014, SOX2 regulates self-renewal and tumorigenicity of human melanoma-initiating cells, Oncogene, 33, 4697, 10.1038/onc.2014.71 · DOI
  96. Basu-Roy, 2012, Sox2 maintains self renewal of tumor-initiating cells in osteosarcomas, Oncogene, 31, 2270, 10.1038/onc.2011.405 · DOI
  97. Ma, 2010, Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3, Acta Biochim. Biophys. Sin. (Shanghai)., 42, 593, 10.1093/abbs/gmq067 · DOI
  98. Yasuda, 2013, Ovarian Cancer stem cells are enriched in side population and aldehyde dehydrogenase bright overlapping population, PLoS One, 8, e68187, 10.1371/journal.pone.0068187 · DOI
  99. Bareiss, 2013, SOX2 expression associates with stem cell state in human ovarian carcinoma, Cancer Res., 73, 5544, 10.1158/0008-5472.CAN-12-4177 · DOI
  100. Wang, 2014, SOX2 enhances the migration and invasion of ovarian cancer cells via Src kinase, PLoS One, 9, e99594, 10.1371/journal.pone.0099594 · DOI
  101. Saigusa, 2009, Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy, Ann. Surg. Oncol., 16, 3488, 10.1245/s10434-009-0617-z · DOI
  102. Wang, 2009, Oct3/4 and sox2 are significantly associated with an unfavorable clinical outcome in human esophageal squamous cell carcinoma, Anticancer Res., 29, 1233
  103. Sholl, 2010, Sox2 protein expression is an independent poor prognostic indicator in stage I lung adenocarcinoma, Am. J. Surg. Pathol., 34, 1193, 10.1097/PAS.0b013e3181e5e024 · DOI
  104. Du, 2011, Sox2 nuclear expression is closely associated with poor prognosis in patients with histologically node-negative oral tongue squamous cell carcinoma, Oral Oncol., 47, 709, 10.1016/j.oraloncology.2011.05.017 · DOI
  105. Wang, 2012, Prognostic significance of SOX2 expression in nasopharyngeal carcinoma, Cancer Invest., 30, 79, 10.3109/07357907.2011.630049 · DOI
  106. Sun, 2013, Sox2 expression predicts poor survival of hepatocellular carcinoma patients and it promotes liver cancer cell invasion by activating Slug, Med. Oncol., 30, 503, 10.1007/s12032-013-0503-1 · DOI
  107. Kong, 2010, Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells, PLoS One, 5, e12445, 10.1371/journal.pone.0012445 · DOI
  108. Han, 2012, Silencing SOX2 induced mesenchymal-epithelial transition and its expression predicts liver and lymph node metastasis of CRC patients, PLoS One, 7, e41335, 10.1371/journal.pone.0041335 · DOI
  109. Li, 2013, SOX2 promotes tumor metastasis by stimulating epithelial-to-mesenchymal transition via regulation of WNT/β-catenin signal network, Cancer Lett., 336, 379, 10.1016/j.canlet.2013.03.027 · DOI
  110. Xia, 2014, Downregulation of miR-638 promotes invasion and proliferation by regulating SOX2 and induces EMT in NSCLC, FEBS Lett., 588, 2238, 10.1016/j.febslet.2014.05.002 · DOI
  111. Yang, 2014, Overexpression of SOX2 promotes migration, invasion, and epithelial-mesenchymal transition through the Wnt/β-catenin pathway in laryngeal cancer Hep-2 cells, J. Immunother. Emphasis Tumor Immunol., 35, 7965
  112. Gao, 2015, SOX2 promotes the epithelial to mesenchymal transition of esophageal squamous cells by modulating slug expression through the activation of STAT3/HIF-α signaling, Int. J. Mol. Sci., 16, 21643, 10.3390/ijms160921643 · DOI
  113. Singh, 2015, Antithetical NFATc1-Sox2 and p53-miR200 signaling networks govern pancreatic cancer cell plasticity, EMBO J., 34, 517, 10.15252/embj.201489574 · DOI
  114. Guo, 2016, Hypoxic microenvironment induces EMT and upgrades stem-like properties of gastric Cancer cells, Technol. Cancer Res. Treat., 15, 60, 10.1177/1533034614566413 · DOI
  115. Jia, 2011, SOX2 promotes tumorigenesis and increases the anti-apoptotic property of human prostate cancer cell, J. Mol. Cell Biol., 3, 230, 10.1093/jmcb/mjr002 · DOI
  116. Neumann, 2011, SOX2 expression correlates with lymph-node metastases and distant spread in right-sided colon cancer, BMC Cancer, 11
  117. Zhang, 2010, SOX2 in gastric carcinoma, but not hath1, is related to patients’ clinicopathological features and prognosis, J. Gastrointest. Surg., 14, 1220, 10.1007/s11605-010-1246-3 · DOI
  118. Wilbertz, 2011, SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer, Mod. Pathol., 24, 944, 10.1038/modpathol.2011.49 · DOI
  119. Bayo, 2015, Loss of SOX2 expression induces cell motility via vimentin up-regulation and is an unfavorable risk factor for survival of head and neck squamous cell carcinoma, Mol. Oncol., 9, 1704, 10.1016/j.molonc.2015.05.006 · DOI
  120. Mukherjee, 2017, Modulation of SOX2 expression delineates an end-point for paclitaxel-effectiveness in breast cancer stem cells, Sci. Rep., 7, 9170, 10.1038/s41598-017-08971-2 · DOI
  121. Li, 2014, Sox2 is involved in paclitaxel resistance of the prostate cancer cell line PC-3 via the PI3K/Akt pathway, Mol. Med. Rep., 10, 3169, 10.3892/mmr.2014.2630 · DOI
  122. Mu, 2017, SOX2 promotes lineage plasticity and antiandrogen resistance in TP53-and RB1-deficient prostate cancer, Science, 355, 84, 10.1126/science.aah4307 · DOI
  123. Li, 2015, Overexpression of SOX2 is involved in paclitaxel resistance of ovarian cancer via the PI3K/Akt pathway, J. Immunother. Emphasis Tumor Immunol., 36, 9823
  124. Jeon, 2011, ID4 imparts chemoresistance and cancer stemness to glioma cells by derepressing miR-9*-mediated suppression of SOX2, Cancer Res., 71, 3410, 10.1158/0008-5472.CAN-10-3340 · DOI
  125. Song, 2016, Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells, J. Chinese Med. Assoc., 79, 538, 10.1016/j.jcma.2016.03.010 · DOI
  126. Tian, 2012, Sox2 enhances the tumorigenicity and chemoresistance of cancer stem-like cells derived from gastric cancer, J. Biomed. Res., 26, 336, 10.7555/JBR.26.20120045 · DOI
  127. Jia, 2018, The role of GLI-SOX2 signaling axis for gemcitabine resistance in pancreatic cancer, Oncogene, 38, 1764, 10.1038/s41388-018-0553-0 · DOI
  128. Lin, 2018, Long noncoding RNA LBCS inhibits self-renewal and chemoresistance of bladder cancer stem cells through epigenetic silencing of SOX2, Clin. Cancer Res., 25, 1389
  129. Shen, 2014, High expression of SOX2 and OCT4 indicates radiation resistance and an independent negative prognosis in cervical squamous cell carcinoma, J. Histochem. Cytochem., 62, 499, 10.1369/0022155414532654 · DOI
  130. Xie, 2016, Rapamycin inhibited the function of lung CSCs via SOX2, J. Immunother. Emphasis Tumor Immunol., 37, 4929
  131. Bora-Singhal, 2015, Gli1-mediated regulation of Sox2 facilitates self-renewal of stem-like cells and confers resistance to EGFR inhibitors in non-small cell lung Cancer, Neoplasia, 17, 538, 10.1016/j.neo.2015.07.001 · DOI
  132. Hüser, 2018, SOX2-mediated upregulation of CD24 promotes adaptive resistance toward targeted therapy in melanoma, Int. J. Cancer, 143, 3131, 10.1002/ijc.31609 · DOI
  133. Rodriguez-Pinilla, 2007, Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer, Mod. Pathol., 20, 474, 10.1038/modpathol.3800760 · DOI
  134. Chen, 2008, The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer, J. Biol. Chem., 283, 17969, 10.1074/jbc.M802917200 · DOI
  135. Long, 2009, SOX2 is highly expressed in squamous cell carcinomas of the gastrointestinal tract, Hum. Pathol., 40, 1768, 10.1016/j.humpath.2009.06.006 · DOI
  136. Gen, 2010, SOX2 identified as a target gene for the amplification at 3q26 that is frequently detected in esophageal squamous cell carcinoma, Cancer Genet. Cytogenet., 202, 82, 10.1016/j.cancergencyto.2010.01.023 · DOI
  137. Schmitz, 2007, Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy, Br. J. Cancer, 96, 1293, 10.1038/sj.bjc.6603696 · DOI
  138. Phi, 2008, Sox2 expression in brain tumors: a reflection of the neuroglial differentiation pathway, Am. J. Surg. Pathol., 32, 103, 10.1097/PAS.0b013e31812f6ba6 · DOI
  139. Freier, 2010, Recurrent copy number gain of transcription factor SOX2 and corresponding high protein expression in oral squamous cell carcinoma, Genes Chromosom. Cancer, 49, 9, 10.1002/gcc.20714 · DOI
  140. Sattler, 2000, Novel amplification unit at chromosome 3q25-q27 in human prostate cancer, Prostate, 45, 207, 10.1002/1097-0045(20001101)45:3<207::AID-PROS2>3.0.CO;2-H · DOI
  141. Güre, 2000, Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer, Proc. Natl. Acad. Sci. U. S. A., 97, 4198, 10.1073/pnas.97.8.4198 · DOI
  142. Rudin, 2012, Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer, Nat. Genet., 44, 1111, 10.1038/ng.2405 · DOI
  143. Lundberg, 2014, SOX2 expression is regulated by BRAF and contributes to poor patient prognosis in colorectal cancer, PLoS One, 9, e101957, 10.1371/journal.pone.0101957 · DOI
  144. Ma, 2008, Expression of stem cell markers in human astrocytomas of different WHO grades, J. Neurooncol., 86, 31, 10.1007/s11060-007-9439-7 · DOI
  145. Kregel, 2013, Sox2 Is an Androgen Receptor-Repressed Gene That Promotes Castration-Resistant Prostate Cancer, PLoS One, 8, e53701, 10.1371/journal.pone.0053701 · DOI
  146. Hussenet, 2010, SOX2 in squamous cell carcinoma: amplifying a pleiotropic oncogene along carcinogenesis, Cell Cycle, 9, 1480, 10.4161/cc.9.8.11203 · DOI
  147. Yuan, 2010, Sex determining region Y-box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung, PLoS One, 5, e9112, 10.1371/journal.pone.0009112 · DOI
  148. Lu, 2010, Evidence that SOX2 overexpression is oncogenic in the lung, PLoS One, 5, e11022, 10.1371/journal.pone.0011022 · DOI
  149. Li, 2004, Expression of the SRY-related HMG box protein SOX2 in human gastric carcinoma, Int. J. Oncol., 24, 257
  150. Tsukamoto, 2005, Sox2 expression in human stomach adenocarcinomas with gastric and gastric-and-intestinal-mixed phenotypes, Histopathology, 46, 649, 10.1111/j.1365-2559.2005.02170.x · DOI
  151. Wuebben, 2017, The dark side of SOX2: cancer - a comprehensive overview, Oncotarget., 8, 44917, 10.18632/oncotarget.16570 · DOI

Cited by

Sorted by citations

Metadata

Authors
Novak, D., Hüser, L., Elton, J. J., Umansky, V., Altevogt, P., & Utikal, J.
Venue
Seminars in Cancer Biology
Publisher
Elsevier BV
Published
2020-12
Volume
67
Pages
74-82
ISSN
1044-579X
DOI
10.1016/j.semcancer.2019.08.007
Cited by
328
References
5
Language
en
Licence
Funders
Deutsche Forschungsgemeinschaft

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review